PCOS Is Now PMOS: What the New Name Means

As of May 12, 2026, the condition long known as PCOS, or polycystic ovary syndrome, has officially been renamed PMOS: polyendocrine metabolic ovarian syndrome.[1]

If your first reaction is, Wait, is this a new condition?, the short answer is no.

This is not a brand-new diagnosis. It is a name change meant to better reflect what clinicians and patients have been saying for years: the old name, polycystic ovary syndrome, did not accurately describe the full condition.[1][2]

For many people, the old name was confusing from the start. Some people diagnosed with PCOS do not have what most patients think of as ovarian cysts, and many of the most important health effects of the condition go far beyond the ovaries.[1][2][3]

The new name, PMOS, is designed to reflect that reality more clearly.

‍

What Does PMOS Stand For?

PMOS stands for polyendocrine metabolic ovarian syndrome.[1]

That may sound more technical, but each part of the name is trying to solve a problem created by the old one:

• Polyendocrine points to the fact that this is a hormone-related condition involving more than one endocrine pathway, not just the ovaries.[1]
• Metabolic highlights the condition’s connection to insulin resistance, weight regulation, type 2 diabetes risk, and other cardiometabolic concerns.[1][2][3]
• Ovarian stays in the name because ovarian function still matters, especially when it comes to ovulation, menstrual cycles, and fertility.[1]
• Syndrome remains because this is still a cluster of related symptoms and findings rather than one single presentation.[1][2]

In other words, PMOS is meant to describe a whole-body condition more accurately than PCOS ever did.

‍

Why Was PCOS Renamed?

The push to rename PCOS did not happen overnight.

According to the Endocrine Society, the change followed 14 years of global collaboration and input from more than 50 patient and professional organizations, with more than 22,000 survey responses helping shape the final decision.[1]

The reason was simple: the old name was leading people in the wrong direction.

For too long, PCOS sounded like a condition that was:

• Mainly about ovarian cysts
• Mostly a fertility issue
• Limited to reproductive symptoms

But that has never been the full story.

The World Health Organization describes the condition as a common hormonal disorder linked not just to irregular periods and ovulatory problems, but also to excess androgen symptoms, infertility, insulin resistance, type 2 diabetes risk, obesity, and longer-term physical and emotional health effects.[2]

The 2023 International Evidence-based Guideline also explicitly acknowledged that the name PCOS was a distraction and supported the process of changing it.[3]

So this rename is really about accuracy.

‍

Why the Old Name Caused So Much Confusion

One of the biggest problems with the term polycystic ovary syndrome is that many people understandably assumed cysts were the defining feature.

They are not.

In fact, current experts involved in the name change process have emphasized that the condition is not defined by an increase in abnormal ovarian cysts.[1] Even under the older PCOS framework, not everyone diagnosed with the condition had polycystic ovaries on imaging, and ovarian appearance was never the whole picture.[2][3]

That misunderstanding had real consequences.

When a name sounds narrow, care often becomes narrow too. Patients may be dismissed if they do not have obvious ovarian findings, or their metabolic symptoms may be underappreciated if the conversation stays centered only on cycles and fertility.

That is part of why the new name matters.

‍

What Symptoms and Health Issues Can PMOS Affect?

One of the strongest arguments for the rename is that this condition can affect much more than one organ system.

Depending on the person, PMOS may be associated with:

• Irregular or absent menstrual periods[2][3]
• Ovulatory dysfunction[2][3]
• Infertility or difficulty conceiving[2][4]
• Acne[2][4]
• Excess facial or body hair[2][4]
• Hair thinning on the scalp[2][4]
• Insulin resistance[2][4]
• Weight and metabolic health changes[1][2]
• Higher long-term risk for type 2 diabetes and cardiovascular disease[1][2][4]
• Sleep apnea, mood symptoms, and broader quality-of-life effects in some patients[3][4]

Not everyone has every symptom, and not everyone’s PMOS looks the same. That variability is part of why the old name fell short.

Does This Change the Diagnosis?

For most patients, the practical answer is not overnight.

The rename is official as of May 12, 2026, but the transition period is expected to unfold over about three years, with full implementation targeted for the 2028 International Guideline update.[1]

That means you will likely still see the term PCOS in patient portals, clinician notes, insurance paperwork, articles, and even official health resources for a while.

More importantly, the name change does not mean your individual diagnosis suddenly disappears or that your doctor has to start from scratch.

The current international guideline still centers diagnosis on the established clinical features of the condition, such as ovulatory dysfunction, androgen excess, and ovarian findings in the right context, while ruling out other causes.[3]

In practical terms, the rename is best understood as a better label for the same clinical condition, not a sudden reinvention of it.

‍

Does PMOS Change Treatment?

Again, not overnight.

Treatment is still based on your symptoms, your goals, and your broader health picture.[2][4][5]

That may include:

• Nutrition and lifestyle support [2][4][5]
• Exercise and weight-management strategies when appropriate [4][5]
• Cycle regulation [4][5]
• Treatment for acne or excess hair growth [4][5]
• Fertility-focused treatment when pregnancy is the goal [4][5]
• Medications that support insulin sensitivity in some cases, such as metformin [5]

So if you already have a PCOS diagnosis, the rename does not mean everything about your care plan suddenly changes.

What it may change over time is how clinicians frame the condition, how quickly patients are recognized, and how often metabolic risks are taken seriously earlier in the process.

‍

Why This Change Could Actually Help Patients

Medical names are not just labels. They shape how people think.

The hope behind PMOS is that a better name may lead to:

• Faster recognition of the condition
• Less confusion around the word cysts
• More attention to insulin resistance and metabolic health
• Better multidisciplinary care
• Less stigma around fertility and reproductive symptoms alone[1]

That matters because the condition is common and still underdiagnosed.

The WHO estimates that PCOS, now PMOS, affects about 10% to 13% of women of reproductive age, and roughly 70% of affected women worldwide may not know they have it.[2]

When a condition is both common and poorly understood, naming is not trivial. It can shape everything from search behavior to referrals to the questions patients ask in the exam room.

‍

What Has Not Changed

Even though the name has changed, a few important things have not:

• PMOS is the same condition previously called PCOS[1]
• You do not need to panic if your chart still says PCOS during the transition
• Not every patient has the same symptoms[2][3][4]
• Treatment should still be individualized[4][5]
• Fertility may be one concern, but it is not the only one[1][2]
• Metabolic health still matters, regardless of whether it was emphasized enough under the old name[1][2][3]

This is an important point for patients: a better name does not automatically guarantee better care, but it can remove one major barrier to better care.

‍

What Patients Should Take Away Right Now

If you have been diagnosed with PCOS, the most useful way to think about this update is:

PCOS is now PMOS, and the new name is meant to describe the condition more accurately.

If you have suspected you may have PCOS, or now PMOS, the rename is also a helpful reminder that this condition is not just about periods or ovaries. It can affect hormones, metabolism, skin, fertility, and long-term health.

That means it is worth bringing up symptoms like:

• Irregular cycles
• Excess facial hair
• Acne
• Hair thinning
• Weight or insulin-resistance concerns
• Difficulty getting pregnant

Those symptoms belong in the same conversation more than the old name sometimes suggested.

‍

The Bottom Line

PMOS is the new name for the condition previously known as PCOS, and the shift is more meaningful than it may look at first glance.

The old name was widely seen as misleading because it overemphasized cysts and ovaries while underrepresenting the condition’s hormonal and metabolic reality. The new name, polyendocrine metabolic ovarian syndrome, is meant to reflect a more accurate, whole-body understanding of the condition.[1][2][3]

What changes immediately for patients is mostly the language. What may change over time, and what advocates and clinicians hope will change, is the quality of recognition, diagnosis, and care.

If you have symptoms that sound like PMOS, or you have been living with a PCOS diagnosis that never fully made sense to you, this is a good time to revisit the bigger picture with a qualified clinician.

‍

FAQ: PCOS vs PMOS

Is PCOS gone now?

No. The condition itself is not gone. It has been officially renamed PMOS, short for polyendocrine metabolic ovarian syndrome, as of May 12, 2026.[1]

What does PMOS stand for?

PMOS stands for polyendocrine metabolic ovarian syndrome.[1]

Is PMOS a new condition?

No. PMOS is the new name for the condition previously known as PCOS. The rename is intended to better reflect the condition’s hormonal and metabolic features.[1][2]

Why was PCOS renamed?

Experts and patient advocates said the old name was misleading because it focused too heavily on ovarian cysts and did not reflect the broader endocrine and metabolic nature of the condition.[1][3]

Do I still have the same diagnosis if my chart says PCOS?

Yes. During the transition period, many records, resources, and portals will still use the term PCOS. That does not mean your diagnosis is different.[1]

Will treatment change because of the new name?

Not automatically. Treatment still depends on your symptoms, health goals, and medical history. The rename is meant to improve understanding and care over time, not instantly rewrite every treatment plan.[2][4][5]

Does PMOS still affect fertility?

Yes. Ovulation and fertility can still be affected, but the new name helps communicate that the condition is not only about fertility or reproductive health.[1][2][4]

Does everyone with PMOS have cysts on their ovaries?

No. That was one of the biggest sources of confusion with the old name. The condition is not defined simply by having ovarian cysts, and not every patient has polycystic ovaries on imaging.[1][2][3]

‍

‍